Impairment of liver synthetic function and decreased liver flow during cyclosporine A therapy.
Leunissen
K M
KM
University Hospital Maastricht, The Netherlands.
Teule
J
J
Degenaar
C P
CP
Kho
T L
TL
Frenken
L A
LA
van Hooff
J P
JP
D000410:Alanine Transaminase / Q000097:blood; D001379:Azathioprine / Q000627:therapeutic use; D001663:Bilirubin / Q000097:blood; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D003524:Cyclosporins / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D016030:Kidney Transplantation / Q000502:physiology*; D008099:Liver / Q000187:drug effects* / Q000378:metabolism; D008102:Liver Circulation / Q000187:drug effects*; D010477:Perfusion; D011239:Prednisolone / Q000627:therapeutic use; D014184:Transplantation, Homologous; D014655:Vascular Resistance / Q000187:drug effects
D003524:Cyclosporins; D011239:Prednisolone; D000410:Alanine Transaminase; D001379:Azathioprine; D001663:Bilirubin